Abstract submission for the 2023 CCRC extended until June 12, 2023!
We received feedback that individuals require additional time and therefore we have extended the submission deadline to 11:59 PM EDT June 12th. Abstracts can be submitted in either English or French and will appear in the language of submission. Posters may be prepared and presented in the presenter’s language of choice. We are encouraging submissions from all researchers working in all areas of cancer research, including health services, biomedical, clinical, social, environmental, and population health. Submit your abstract here
New Funding Opportunity from CIHR
CIHR’s Health Effects of Vaping Catalyst Grant funding opportunity will support projects relevant to the following research areas:
- Youth vaping of nicotine, cannabinoid extracts, THC, and other compounds
- Short and/or long-term health effects of vaping (including ... Read More »
CIHR’s Health Effects of Vaping Catalyst Grant funding opportunity will support projects relevant to the following research areas:
- Youth vaping of nicotine, cannabinoid extracts, THC, and other compounds
- Short and/or long-term health effects of vaping (including ... Read More »
The 3CTN EDI Framework and Toolkit is Launched
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri... Read More »
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri... Read More »